166 related articles for article (PubMed ID: 32548285)
1. The Longitudinal Imaging Tracker (BrICS-LIT):A Cloud Platform for Monitoring Treatment Response in Glioblastoma Patients.
Ramesh K; Gurbani SS; Mellon EA; Huang V; Goryawala M; Barker PB; Kleinberg L; Shu HG; Shim H; Weinberg BD
Tomography; 2020 Jun; 6(2):93-100. PubMed ID: 32548285
[TBL] [Abstract][Full Text] [Related]
2. The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow.
Gurbani S; Weinberg B; Cooper L; Mellon E; Schreibmann E; Sheriff S; Maudsley A; Goryawala M; Shu HK; Shim H
Tomography; 2019 Mar; 5(1):184-191. PubMed ID: 30854456
[TBL] [Abstract][Full Text] [Related]
3. A brain tumor reporting and data system to optimize imaging surveillance and prognostication in high-grade gliomas.
Kim S; Hoch MJ; Peng L; Somasundaram A; Chen Z; Weinberg BD
J Neuroimaging; 2022 Nov; 32(6):1185-1192. PubMed ID: 36045502
[TBL] [Abstract][Full Text] [Related]
4. Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.
Qin L; Li X; Stroiney A; Qu J; Helgager J; Reardon DA; Young GS
Neuroradiology; 2017 Feb; 59(2):135-145. PubMed ID: 28070598
[TBL] [Abstract][Full Text] [Related]
5. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy.
Förster A; Böhme J; Maros ME; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Wenz F; Groden C; Pope WB; Giordano FA
J Neuroradiol; 2020 Mar; 47(2):166-173. PubMed ID: 30659892
[TBL] [Abstract][Full Text] [Related]
7. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.
Li Y; Ma Y; Wu Z; Xie R; Zeng F; Cai H; Lui S; Song B; Chen L; Wu M
Front Immunol; 2021; 12():790674. PubMed ID: 34899760
[TBL] [Abstract][Full Text] [Related]
8. Radiomics signature for temporal evolution and recurrence patterns of glioblastoma using multimodal magnetic resonance imaging.
Chougule T; Gupta RK; Saini J; Agrawal S; Gupta M; Vakharia N; Singh A; Patir R; Vaishya S; Ingalhalikar M
NMR Biomed; 2022 Mar; 35(3):e4647. PubMed ID: 34766380
[TBL] [Abstract][Full Text] [Related]
9. A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.
Ramesh KK; Huang V; Rosenthal J; Mellon EA; Goryawala M; Barker PB; Gurbani SS; Trivedi AG; Giuffrida AS; Schreibmann E; Han H; de le Fuente M; Dunbar EM; Holdhoff M; Kleinberg LR; Shu HG; Shim H; Weinberg BD
Tomography; 2023 Feb; 9(1):362-374. PubMed ID: 36828381
[TBL] [Abstract][Full Text] [Related]
10. Using Brain Tumor MRI Structured Reporting to Quantify the Impact of Imaging on Brain Tumor Boards.
Abidi SA; Hoch MJ; Hu R; Sadigh G; Voloschin A; Olson JJ; Shu HG; Neill SG; Weinberg BD
Tomography; 2023 Apr; 9(2):859-870. PubMed ID: 37104141
[TBL] [Abstract][Full Text] [Related]
11. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
12. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
[TBL] [Abstract][Full Text] [Related]
13. Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy.
George E; Kijewski MF; Dubey S; Belanger AP; Reardon DA; Wen PY; Kesari S; Horky L; Park MA; Huang RY
AJR Am J Roentgenol; 2018 Dec; 211(6):1342-1347. PubMed ID: 30332289
[TBL] [Abstract][Full Text] [Related]
14. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
[TBL] [Abstract][Full Text] [Related]
15. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
[TBL] [Abstract][Full Text] [Related]
16. Does interventional MRI-guided brain cryotherapy cause a blood-brain barrier disruption? Radiological analysis and perspectives.
Mallereau CH; Baloglu S; Chibbaro S; Noblet V; Todeschi J; Noel G; Gangi A; De Mathelin M; Proust F; Cebula H
Neurosurg Rev; 2022 Apr; 45(2):1421-1429. PubMed ID: 34613525
[TBL] [Abstract][Full Text] [Related]
17. Final Results of the Prospective Biomarker Trial PETra: [
Seidlitz A; Beuthien-Baumann B; Löck S; Jentsch C; Platzek I; Zöphel K; Linge A; Kotzerke J; Petr J; van den Hoff J; Steinbach J; Krex D; Schmitz-Schackert G; Falk M; Baumann M; Krause M
Clin Cancer Res; 2021 Mar; 27(5):1351-1360. PubMed ID: 33376095
[TBL] [Abstract][Full Text] [Related]
18. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
20. Advanced magnetic resonance imaging in glioblastoma: a review.
Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
